| HR (95% CI) | ||
---|---|---|---|
Model 1 | Model 2 | Model 3 | |
All-cause mortality | Â | Â | Â |
Leukocyte | 1.03 (1.03, 1.04) | 1.02 (1.02, 1.03) | 1.02 (1.01, 1.03) |
Neutrophil | 1.20 (1.16, 1.24) | 1.16 (1.11, 1.20) | 1.18 (1.11, 1.20) |
Lymphocyte | 1.02 (0.99, 1.04) | 1.01 (1.00, 1.03) | 1.01 (0.99, 1.03) |
NLR | 1.19 (1.16, 1.21) | 1.13 (1.10, 1.16) | 1.11 (1.09, 1.14) |
SII | 1.00 (1.00, 1.00) | 1.00 (1.00, 1.00) | 1.00 (1.00, 1.00) |
Cardiovascular mortality | Â | Â | Â |
Leukocyte | 1.02 (1.00, 1.05) | 1.01 (0.99, 1.04) | 1.01 (0.98, 1.03) |
Neutrophil | 1.17 (1.10, 1.25) | 1.13 (1.06, 1.21) | 1.17 (1.09, 1.25) |
Lymphocyte | 0.65 (0.54, 0.78) | 0.79 (0.66, 0.95) | 0.83 (0.69, 0.99) |
NLR | 1.19 (1.15, 1.23) | 1.13 (1.08, 1.18) | 1.11 (1.07, 1.16) |
SII | 1.00 (1.00, 1.00) | 1.00 (1.00, 1.00) | 1.00 (1.00, 1.00) |